The manufacturers of these medications have the responsibility of ensuring the public that their product is safe and effective, prolonging their chance of living without getting any risk to their health and safety.
Victims on Purdue Pharma’s deceptive marketing practices want justice.
The market for non-opioid pain treatment options is increasing, according to recent data.
Coronavirus patients on ventilators are feeling the pinch of federal drug quotas.
Suboxone film drugmaker settles federal probe finding it misrepresented the drug’s benefits.
The Food and Drug Administration requires Narcan information to be present on the labels of prescription opioids.
The American Medical Association Opioid Task Force believes barriers need to be removed for evidence-based treatments.
Legal experts suggest the Sacklers may just get their way after all.
The Non-Opioids Prevent Addiction in the Nation Act aims to get Medicare to cover safe pain alternatives.
The HHS has rolled out a new coronavirus tracking database meant to replace the CDC’s system.